Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$7.71 - $11.56 $48,218 - $72,296
-6,254 Reduced 22.89%
21,072 $244 Million
Q3 2023

Nov 03, 2023

BUY
$8.91 - $10.91 $243,474 - $298,126
27,326 New
27,326 $250 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.